International Journal of Molecular Sciences· 2026Q1· Review
Harnessing Neurogenic Potential of Glial Cell Types as an Emerging Strategy for Treating Epilepsy
- 0citations
- Q1SCImago
- 2026year
Short summary
Researchers propose converting resident glial cells into neurons as a novel strategy to treat epilepsy, particularly for the third of cases unresponsive to current drugs.
AI-generated from the title and abstract; the full text is not read.
Key points
- Epilepsy treatment faces challenges with drug-resistant cases, driving the search for new therapeutic avenues.
- Glial cells possess inherent, albeit limited, neurogenic potential that can be exploited.
- Neuronal transdifferentiation methods offer a pathway to convert glial cells into functional neurons.
- Glia-to-neuron conversion is a promising strategy to address neuronal loss and gliosis in epilepsy.
AI-generated from the title and abstract; the full text is not read.
Abstract
In every third case of epilepsy, anti-seizure drugs are ineffective, so the search for new therapies for this disease is ongoing. In recent years, new methods for generating cells with desired properties, as well as for the targeted expression of genes in specific cell types in situ within the brain, were designed. These methods allowed researchers to consider the idea of transforming resident glial cells into neurons in conditions like epilepsy; in such pathologies it may rescue both neuronal loss and gliosis. In this review, we describe epilepsy-associated pathological changes in glial cells, the neurogenic potential of different glial types (their similarities to neural stem cells and their inherent limited ability to produce neurons in response to brain damage), and existing methods of neuronal transdifferentiation starting with different cell types with varying proximity in lineage distance to neurons. Based on overlaps between these topics, we make conclusions about the applicability of glia-to-neuron conversion in treating epilepsy and the most important challenges that should be considered in designing experiments and clinical trials for this strategy.
The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Developmental Neuroscience
Developmental NeuroscienceNeuroscience